Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David A Bushinsky

Showing results (81-90 of 128) with videos related to

Pageof 13
Sort By:
Lancet (London, England)|March 13, 2019
Veverimer versus placebo in patients with metabolic acidosis associated with chronic kidney disease: a multicentre, randomised, double-blind, controlled, phase 3 trialDonald E Wesson, Vandana Mathur, Navdeep Tangri, et al.
Elife|August 9, 2022
Modeling osteoporosis to design and optimize pharmacological therapies comprising multiple drug typesDavid J Jörg, Doris H Fuertinger, Alhaji Cherif, et al.
Lancet (London, England)|June 29, 2019
Long-term safety and efficacy of veverimer in patients with metabolic acidosis in chronic kidney disease: a multicentre, randomised, blinded, placebo-controlled, 40-week extensionDonald E Wesson, Vandana Mathur, Navdeep Tangri, et al.
Journal of the American Society of Nephrology : JASN|April 14, 2006
Isolation and confirmation of a calcium excretion quantitative trait locus on chromosome 1 in genetic hypercalciuric stone-forming congenic ratsRichard R Hoopes, Frank A Middleton, Saunak Sen, et al.
Kidney International|January 8, 2021
Chlorthalidone with potassium citrate decreases calcium oxalate stones and increases bone quality in genetic hypercalciuric stone-forming ratsNancy S Krieger, John Asplin, Ignacio Granja, et al.
Clinical Kidney Journal|July 3, 2023
Association of serum bicarbonate with the development of kidney stones in patients with chronic kidney disease: a retrospective cohort studyNavdeep Tangri, Vandana Mathur, Nancy L Reaven, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 4, 2008
Combined therapy with cinacalcet and low doses of vitamin D sterols in patients with moderate to severe secondary hyperparathyroidismGeoffrey A Block, Steven Zeig, Jared Sugihara, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 13, 2019
Association between dietary zinc intake and abdominal aortic calcification in US adultsWei Chen, Ruth Eisenberg, Wenzhu B Mowrey, et al.
Hemodialysis International. International Symposium on Home Hemodialysis|November 29, 2011
Self-reported symptoms in patients on hemodialysis with moderate to severe secondary hyperparathyroidism receiving combined therapy with cinacalcet and low-dose vitamin D sterolsGlenn M Chertow, Z John Lu, Xiao Xu, et al.
Plos One|April 27, 2013
Epigenetic regulation of BMP2 by 1,25-dihydroxyvitamin D3 through DNA methylation and histone modificationBaisheng Fu, Hongwei Wang, Jinhua Wang, et al.
Pageof 13

Showing results (81-90 of 128) with videos related to

Sort By:
Pageof 13
Lancet (London, England)|March 13, 2019
Veverimer versus placebo in patients with metabolic acidosis associated with chronic kidney disease: a multicentre, randomised, double-blind, controlled, phase 3 trialDonald E Wesson, Vandana Mathur, Navdeep Tangri, et al.
Elife|August 9, 2022
Modeling osteoporosis to design and optimize pharmacological therapies comprising multiple drug typesDavid J Jörg, Doris H Fuertinger, Alhaji Cherif, et al.
Lancet (London, England)|June 29, 2019
Long-term safety and efficacy of veverimer in patients with metabolic acidosis in chronic kidney disease: a multicentre, randomised, blinded, placebo-controlled, 40-week extensionDonald E Wesson, Vandana Mathur, Navdeep Tangri, et al.
Journal of the American Society of Nephrology : JASN|April 14, 2006
Isolation and confirmation of a calcium excretion quantitative trait locus on chromosome 1 in genetic hypercalciuric stone-forming congenic ratsRichard R Hoopes, Frank A Middleton, Saunak Sen, et al.
Kidney International|January 8, 2021
Chlorthalidone with potassium citrate decreases calcium oxalate stones and increases bone quality in genetic hypercalciuric stone-forming ratsNancy S Krieger, John Asplin, Ignacio Granja, et al.
Clinical Kidney Journal|July 3, 2023
Association of serum bicarbonate with the development of kidney stones in patients with chronic kidney disease: a retrospective cohort studyNavdeep Tangri, Vandana Mathur, Nancy L Reaven, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 4, 2008
Combined therapy with cinacalcet and low doses of vitamin D sterols in patients with moderate to severe secondary hyperparathyroidismGeoffrey A Block, Steven Zeig, Jared Sugihara, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 13, 2019
Association between dietary zinc intake and abdominal aortic calcification in US adultsWei Chen, Ruth Eisenberg, Wenzhu B Mowrey, et al.
Hemodialysis International. International Symposium on Home Hemodialysis|November 29, 2011
Self-reported symptoms in patients on hemodialysis with moderate to severe secondary hyperparathyroidism receiving combined therapy with cinacalcet and low-dose vitamin D sterolsGlenn M Chertow, Z John Lu, Xiao Xu, et al.
Plos One|April 27, 2013
Epigenetic regulation of BMP2 by 1,25-dihydroxyvitamin D3 through DNA methylation and histone modificationBaisheng Fu, Hongwei Wang, Jinhua Wang, et al.
Pageof 13